Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

BUY
$20.28 - $27.0 $941,600 - $1.25 Million
46,430 Added 86.67%
100,000 $2.68 Million
Q1 2023

May 15, 2023

BUY
$20.76 - $30.09 $1.11 Million - $1.61 Million
53,570 New
53,570 $1.16 Million
Q2 2021

Aug 16, 2021

SELL
$29.0 - $47.44 $986,348 - $1.61 Million
-34,012 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$37.21 - $54.43 $1.27 Million - $1.85 Million
34,012 New
34,012 $1.51 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.8B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.